DKSH Holding Ltd (DKSHF) Full Year 2025 Earnings Call Highlights: Strategic Growth and Dividend ...

DKSH Holding Ltd (DKSHF) Full Year 2025 Earnings Call Highlights: Strategic Growth and Dividend …

GuruFocus News

Wed, February 18, 2026 at 2:01 AM GMT+9 4 min read

In this article:

DKSHF

-12.25%

This article first appeared on GuruFocus.

**Net Sales:** Increased by 2.9% at constant exchange rates to CHF11.1 billion in 2025.
**Core EBIT:** Amounted to CHF349 million, a 6.7% increase from 2024, with a margin increase from 3.1% to 3.2%.
**Free Cash Flow:** CHF215.5 million with a cash conversion of 95.2%.
**Ordinary Dividend:** Proposed increase by 6.4% to CHF2.50 per share.
**Healthcare Unit Net Sales:** Increased by 4.6% to CHF5.8 billion.
**Consumer Goods Unit Net Sales:** Grew by 1.2%, with a 2.8% increase in the second half of 2025.
**Performance Materials Unit Net Sales:** Grew by 1.4% to CHF1.4 billion.
**Core Profit After Tax:** CHF226.4 million, a 3.3% increase at constant exchange rates.
**Core Return on Equity:** Increased by 30 basis points to 12.4%.
**Core EBIT Margin:** Improved to 3.2%, marking the fifth consecutive year of expansion.
**Capital Expenditure:** Expected to remain between 0.3% and 0.4% of net sales for the full year.
Warning! GuruFocus has detected 10 Warning Signs with WBD.
High Yield Dividend Stocks in Gurus' Portfolio
This Powerful Chart Made Peter Lynch 29% A Year For 13 Years
How to calculate the intrinsic value of a stock?
Is DKSHF fairly valued? Test your thesis with our free DCF calculator.

Release Date: February 17, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

DKSH Holding Ltd (DKSHF) reported a net sales increase of 2.9% at constant exchange rates, reaching CHF11.1 billion in 2025.
Core EBIT rose by 6.7% to CHF349 million, with a margin increase from 3.1% to 3.2%, aligning with the company's mid-term goal.
The company achieved a high free cash flow of CHF215.5 million, marking a cash conversion rate of 95.2%, surpassing the target of 90%.
DKSH Holding Ltd (DKSHF) announced nine accretive M&A transactions in 2025, contributing to growth and strategic expansion.
The company proposed a 6.4% increase in the ordinary dividend, marking the 13th consecutive year of dividend growth, reinforcing its dividend aristocrat status.

Negative Points

Despite overall growth, the consumer goods business unit experienced a decline in core EBIT by 4.3% in the first half of 2025.
The technology business unit faced challenges due to macroeconomic uncertainty, resulting in performance around 2024 levels.
Currency fluctuations negatively impacted net sales by 3.1%, affecting the overall financial performance.
The performance materials business unit faced a challenging market environment, with net sales growth of only 1.4%.
The company experienced a volatile M&A environment, with some major transactions not materializing as expected.

 






Story continues  

Q & A Highlights

Q: Can you elaborate on the changes in the consumer segment and the impact of AI on growth and logistics costs? A: Ido Wallach, CFO, explained that the consumer segment’s improvement is due to a strategic pivot towards better and bigger business, focusing on higher premium categories and increased distribution efficiency. AI has been instrumental in optimizing logistics, reducing costs by CHF35 million through automation and efficient routing. AI also presents opportunities for revenue growth by optimizing sales routes and product recommendations.

Q: How is DKSH progressing in shifting towards higher-margin businesses in healthcare, and what is the impact of AI on margins? A: Stefan Butz, CEO, stated that DKSH has increased its focus on high-margin businesses, with commercial outsourcing contributing 55% to EBIT in 2025. The company expects to continue this trend, increasing margins by 10 basis points annually. AI is expected to enhance efficiency and productivity, potentially improving margins, but it’s too early to quantify the impact.

Q: How is DKSH protected from Chinese competition in performance materials, and what is the share of USD-denominated sales? A: Stefan Butz highlighted that DKSH’s strong connections with Chinese suppliers and distribution within China provide resilience against competition. The company has a broad customer base in Asia, which accounts for two-thirds of its business. Ido Wallach added that USD-denominated sales are minimal, around 1% to 2%, with currency risks being primarily translational.

Q: Can you comment on the trends in performance materials and the tariff environment in India and China? A: Stefan Butz noted that performance materials experienced a rocky 2025, with fluctuations due to tariff discussions. However, there is optimism for 2026, especially in Asia. The tariff impact is expected to be limited, with supply chains shifting towards Southeast Asia. Ido Wallach mentioned that inventory levels are healthy, with no significant regional or product-specific concerns.

Q: What are the drivers behind the promising business development pipeline in the technology business for 2026? A: Stefan Butz explained that delayed projects from 2025, strong order intake in scientific instrumentation, and investments in data centers are building a strong pipeline for 2026. These factors contribute to the expectation of a strong rebound in the technology business.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Terms and Privacy Policy

Privacy Dashboard

More Info

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin